ABSTRACT
Shark variable new antigen receptors (VNARs) are known to possess excellent heat-stability, and the long complementarity determining region 3 (CDR3) has permitted it to penetrate into the cleft region of antigens. The number of cysteine (Cys) residues contained within VNAR is greater than in conventional antibodies, entailing disulfide bond formation in both the inter- or intra-loop regions is required for interactions with the target protein antigens. Therefore, the selection of a suitable expression system is important to ensure the solubility and correct folding of functional VNAR protein production. Unlike higher organisms, the machinery for effecting posttranslational modifications of proteins in Escherichia coli (E. coli) are less sophisticated. To overcome this circumstance, a pDSB-28Y vector fusion with DsbA signal peptide was engineered for periplasmic H8VNAR production. Despite the periplasmic proteins showing a lower yield (62 µg/mL) than cytosolic proteins (468 µg/mL) that is obtained from pET-28a vector, it has demonstrated better performance than that of a cytosolic protein in terms of absorbance. However, these readings were still inferior to that of positive control mouse monoclonal antibody (mAb) C1-13 in this experiment. Therefore, further investigation is required to improve the binding affinity of selected recombinant VNAR towards malaria biomarkers.
Subject(s)
Antigens, Protozoan/immunology , Protozoan Proteins/immunology , Recombinant Proteins/immunology , Single-Domain Antibodies/immunology , Animals , Cloning, Molecular/methods , Cytosol/metabolism , Escherichia coli/genetics , Escherichia coli/metabolism , Periplasm/metabolism , Plasmodium falciparum/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Sharks , Single-Domain Antibodies/genetics , Single-Domain Antibodies/isolation & purificationABSTRACT
BACKGROUND: Malaria rapid diagnostic tests (RDTs) represent an important antibody based immunoassay platform. Unfortunately, conventional monoclonal antibodies are subject to degradation shortening shelf lives of RDTs. The variable region of the receptor (VNAR) from shark has a potential as alternative to monoclonal antibodies in RDTs due to high thermal stability. METHODS: In this study, new binders derived from shark VNAR domains library were investigated. Following immunization of a wobbegong shark (Orectolobus ornatus) with three recombinant malaria biomarker proteins (PfHRP2, PfpLDH and Pvaldolase), a single domain antibody (sdAb) library was constructed from splenocytes. Target-specific VNAR phage were isolated by panning. One specific clone was selected for expression in Escherichia coli expression system, and study of binding reactivity undertaken. RESULTS: The primary VNAR domain library possessed a titre of 1.16 × 106 pfu/mL. DNA sequence analysis showed 82.5% of isolated fragments appearing to contain an in-frame sequence. After multiple rounds of biopanning, a highly dominant clone specific to PfHRP2 was identified and selected for protein production in an E. coli expression system. Biological characterization showed the recombinant protein expressed in periplasmic has better detection sensitivity than that of cytoplasmic proteins. Assays of binding activity indicated that its reactivity was inferior to the positive control mAb C1-13. CONCLUSIONS: Target-specific bacteriophage VNARs were successfully isolated after a series of immunization, demonstrating that phage display technology is a useful tool for selection of antigen binders. Generation of new binding reagents such as VNAR antibodies that specifically recognize the malaria biomarkers represents an appealing approach to improve the performance of RDTs.
Subject(s)
Antibodies, Protozoan/metabolism , Diagnostic Tests, Routine , Malaria/diagnosis , Protozoan Proteins/metabolism , Sharks , Animals , Antibodies, Monoclonal/metabolism , Biomarkers , Escherichia coli/metabolism , Mice , Peptide Library , Recombinant Proteins/metabolism , Sharks/immunologyABSTRACT
Mast cells are immune cells that produce and secrete a variety of mediators and cytokines that influence various inflammatory and immune processes. Leptin is a cytokine regulating metabolic, endocrine as well as immune functions via the leptin receptor which is expressed by many immune cells. However, there are no data about leptin receptor expression in mast cells. Immunohistochemical and immunofluorescent double stainings showed the expression of leptin and leptin receptors in mast cells in human skin and several parts of the respiratory, gastrointestinal and urogenital tract. Leptin was expressed in mast cells expressing the classification marker chymase, whereas a variable expression was observed in tryptase positive mast cells. For leptin receptors, the expression pattern was tissue dependent and not related to tryptase or chymase expression. Our results demonstrate the expression of leptin and leptin receptors on mast cells, suggesting paracrine and/or autocrine immunomodulatory effects of leptin on mast cells.
Subject(s)
Leptin/metabolism , Mast Cells/metabolism , Receptors, Leptin/metabolism , Chymases/metabolism , Humans , Mast Cells/cytology , Tryptases/metabolismABSTRACT
The brain is composed of neurons that communicate electrical signals over neurites and chemical signals across synapses, and non-neuronal cells like glial and vascular cells that communicate calcium signals among each other Calcium ions have an important signaling function in the cytoplasm that depends on their amplitude, time course of change and subcellular localisation. Work over the last decade has added an additional dimension to this rich repertoire by including the possibility that calcium signals can be communicated between cells. In astrocytes and endothelial cells, connexins appear to be at the crossroad of calcium signal communication pathways, because they are the building blocks of gap junction channels that functionally connect cells, and because they can arrange as hemichannels that act as a conduit for cellular ATP release, thus initiating paracrine purinergic signaling. The two pathways appear to be operational in astrocytes and endothelial cells and we review in this paper possible functions of astrocyte-to-blood vessel calcium signaling at the level of arterioles where blood flow is controlled, at the level of capillaries where the blood-brain barrier is located and at the level of blood immune cells.
Subject(s)
Calcium Signaling/physiology , Cell Communication/physiology , Endothelium, Vascular/physiology , Neuroglia/physiology , Animals , Brain/cytology , Brain/physiology , Endothelium, Vascular/cytology , Humans , Neuroglia/cytologyABSTRACT
The communication of calcium signals between cells is known to be operative between neurons where these signals integrate intimately with electrical and chemical signal communication at synapses. Recently, it has become clear that glial cells also exchange calcium signals between each other in cultures and in brain slices. This communication pathway has received utmost attention since it is known that astrocytic calcium signals can be induced by neuronal stimulation and can be communicated back to the neurons to modulate synaptic transmission. In addition to this, cells that are generally not considered as brain cells become progressively incorporated in the picture, as astrocytic calcium signals are reported to be communicated to endothelial cells of the vessel wall and can affect smooth muscle cell tone to influence the vessel diameter and thus blood flow. We review the available evidence for calcium signal communication in the central nervous system, taking into account a basic functional unit -the brain cell tripartite- consisting of neurons, glial cells and vascular cells and with emphasis on glial-vascular calcium signaling aspects.
Subject(s)
Calcium Signaling/physiology , Cell Communication/physiology , Central Nervous System/metabolism , Animals , Central Nervous System/cytology , Gap Junctions/chemistry , Gap Junctions/physiology , Humans , Paracrine CommunicationABSTRACT
The breaching of the blood-brain barrier is an essential aspect in the pathogenesis of neuroinflammatory diseases, in which tumour necrosis factor alpha (TNF-alpha) as well as endothelial calcium ions play a key role. We investigated whether TNF-alpha could influence the communication of calcium signals between brain endothelial cells (GP8 and RBE4). Intercellular calcium waves triggered by mechanical stimulation or photoliberation of InsP3 in single cells were significantly reduced in size after TNF-alpha exposure (1000 U/mL, 2 and 24 h). Calcium signals are communicated between cells by means of gap junctional and paracrine purinergic signalling. TNF-alpha significantly inhibited gap junctional coupling, stimulated the basal release of ATP, and dose-dependently blocked the triggered component of ATP release. The cytokine displayed similar effects on the uptake of a fluorescent reporter dye into the cells. Previous work with connexin mimetic peptides demonstrated that the triggered ATP release in these cells is connexin-related; these peptides did, however, not influence the elevated basal ATP release caused by TNF-alpha. We conclude that TNF-alpha depresses calcium signal communication in blood-brain barrier endothelial cells, by reducing gap junctional coupling and by inhibiting triggered ATP release. The cytokine thus inhibits connexin-related communication pathways like gap junctions and connexin hemichannels.
Subject(s)
Blood-Brain Barrier/metabolism , Calcium Signaling/physiology , Endothelial Cells/metabolism , Purinergic Antagonists , Tumor Necrosis Factor-alpha/physiology , Animals , Cell Line , Endothelial Cells/physiology , Gap Junctions/metabolism , Gap Junctions/physiology , Rats , Receptors, Purinergic/metabolismABSTRACT
Photolytic liberation of InsP(3) in single cells triggers cell-to-cell propagating calcium changes that are communicated by a gap junctional and a paracrine purinergic pathway involving InsP(3)-triggered ATP release. We investigated the relation between the InsP(3) stimulus and the resulting ATP release in ECV304 cells using UV photolysis of caged compounds and bioluminescent ATP measurements. Careful consideration of all steps, starting from caged InsP(3) loading into the cells by electroporation, up to photoliberation upon UV exposure, allowed to derive a dose-response relation that revealed a first part with a flattening ATP release response in the below 10microM InsP(3) concentration range and a second phase of steeply increasing ATP release in response to above 10microM InsP(3) stimulation. ATP release triggered by below 10microM InsP(3) concentrations attained a level in the order of 30% above baseline ATP release, while the steeply increasing response to high InsP(3) concentrations attained values in the order of 150% above baseline. Our data indicate the involvement of low affinity InsP(3) receptor sites in the pathway leading to triggered ATP release, with activation of these receptors causing the release of 1-2% of the total cellular ATP pool.
Subject(s)
Adenosine Triphosphate/metabolism , Electroporation/methods , Inositol 1,4,5-Trisphosphate/metabolism , Photolysis , Aniline Compounds/metabolism , Calcium/metabolism , Cell Line , Dose-Response Relationship, Drug , Electroporation/instrumentation , Endothelial Cells , Humans , Lighting/methods , Time Factors , Ultraviolet Rays , Umbilical Cord , Xanthenes/metabolismABSTRACT
Connexin hemichannels, that is, half gap junction channels (not connecting cells), have been implicated in the release of various messengers such as ATP and glutamate. We used connexin mimetic peptides, which are, small peptides mimicking a sequence on the connexin subunit, to investigate hemichannel functioning in endothelial cell lines. Short exposure (30 min) to synthetic peptides mimicking a sequence on the first or second extracellular loop of the connexin subunit strongly supressed ATP release and dye uptake triggered by either intracellular InsP(3) elevation or exposure to zero extracellular calcium, while gap junctional coupling was not affected under these conditions. The effect was dependent on the expression of connexin-43 in the cells. Connexin mimetic peptides thus appear to be interesting tools to distinguish connexin hemichannel from gap junction channel functioning. In addition, they are well suited to further explore the role of connexins in cellular release or uptake processes, to investigate hemichannel gating and to reveal new unknown functions of the large conductance hemichannel pathway between the cell and its environment. Work performed up to now with these peptides should be re-interpreted in terms of these new findings.
Subject(s)
Adenosine Triphosphate/metabolism , Cell Communication/drug effects , Connexins/metabolism , Gap Junctions/physiology , Peptides/pharmacology , Amino Acid Sequence , Animals , Calcium/metabolism , Cells, Cultured , Endothelial Cells/metabolism , HeLa Cells , Humans , Molecular Sequence Data , Propidium , Tumor Necrosis Factor-alpha/metabolismABSTRACT
Recently, ATP has gained much interest as an extracellular messenger involved in the communication of calcium signals between cells. The mechanism of ATP release is, however, still a matter of debate. In the present study we investigated the possible contribution of connexin hemichannels or ion channels in the release of ATP in GP8, a rat brain endothelial cell line. Release of ATP was triggered by photoactivation of InsP(3) or by reducing the extracellular calcium concentration. Both trigger protocols induced ATP release significantly above baseline. InsP(3)-triggered ATP release was completely blocked by alpha-glycyrrhetinic acid (alpha-GA), the connexin mimetic peptides gap 26 and 27, and the trivalent ions gadolinium and lanthanum. ATP release triggered by zero calcium was, in addition to these substances, also blocked by flufenamic acid (FFA), niflumic acid, and NPPB. Gap 27 selectively blocked zero calcium-triggered ATP release in connexin-43 transfected HeLa cells, while having no effect in wild-type and connexin-32 transfected cells. Of all the agents used, only alpha-GA, FFA and NPPB significantly reduced gap junctional coupling. In conclusion, InsP(3) and zero calcium-triggered ATP release show major similarities but also some differences in their sensitivity to the agents applied. It is suggested that both stimuli trigger ATP release through the same mechanism, which is connexin-dependent, permeable in both directions, potently blocked by connexin mimetic peptides, and consistent with the opening of connexin hemichannels.
Subject(s)
Adenosine Triphosphate/metabolism , Blood-Brain Barrier/drug effects , Brain/blood supply , Brain/metabolism , Calcium/deficiency , Endothelium, Vascular/drug effects , Endothelium, Vascular/metabolism , Inositol 1,4,5-Trisphosphate/analogs & derivatives , Inositol 1,4,5-Trisphosphate/metabolism , Animals , Blood-Brain Barrier/physiology , Cells, Cultured , Connexin 43/drug effects , Connexin 43/genetics , Connexin 43/metabolism , Connexins/drug effects , Connexins/genetics , Connexins/metabolism , Connexins/pharmacology , Extracellular Space/metabolism , Flufenamic Acid/pharmacology , Gadolinium/pharmacology , Gap Junctions/drug effects , Gap Junctions/metabolism , Glycyrrhetinic Acid/pharmacology , Humans , Inositol 1,4,5-Trisphosphate/pharmacology , Inositol 1,4,5-Trisphosphate/radiation effects , Lanthanum/pharmacology , Niflumic Acid/pharmacology , Nitrobenzoates/pharmacology , Oligopeptides , Rats , Ultraviolet Rays , Gap Junction beta-1 ProteinABSTRACT
Calcium signals can be communicated between cells by the diffusion of a second messenger through gap junction channels or by the release of an extracellular purinergic messenger. We investigated the contribution of these two pathways in endothelial cell lines by photoliberating InsP(3) or calcium from intracellular caged precursors, and recording either the resulting intercellular calcium wave or else the released ATP with a luciferin/luciferase assay. Photoliberating InsP(3) in a single cell within a confluent culture triggered an intercellular calcium wave, which was inhibited by the gap junction blocker alpha-glycyrrhetinic acid (alpha-GA), the connexin mimetic peptide gap 26, the purinergic inhibitors suramin, PPADS and apyrase and by purinergic receptor desensitisation. InsP(3)-triggered calcium waves were able to cross 20 microm wide cell-free zones. Photoliberating InsP(3) triggered ATP release that was blocked by buffering intracellular calcium with BAPTA and by applying gap 26. Gap 26, however, did not inhibit the gap junctional coupling between the cells as measured by fluorescence recovery after photobleaching. Photoliberating calcium did not trigger intercellular calcium waves or ATP release. We conclude that InsP(3)-triggered ATP release through connexin hemichannels contributes to the intercellular propagation of calcium signals.